Background: Previous studies have shown that patients with non-communicable diseases (NCDs) had a higher risk of coronavirus disease 2019 (COVID-19). This study aimed to evaluate the associated factors and global impact of the presence of NCDs on COVID-19 related experience, behaviours, and mental health outcomes. Methods: We conducted a global survey involving 26 countries by an online, self-administered questionnaire (October 2020–December 2021). Data on sociodemographic variables, socioeconomic status, and clinical information were collected among adults aged ≥18 years. We examined factors associated with the presence of NCDs and evaluated whether they were correlated with COVID-19 related experience, behaviours, and mental health outcomes by binary logistic regression. Results: We collected a total of 2,576 surveys, of which 729 participants (28.3%) had existing NCDs. Participants with NCDs were more likely to suffer from COVID-19 symptoms [adjusted odds ratio (aOR) =3.71, 95% confidence interval (CI): 2.65–5.18], infections (aOR =1.81, 95% CI: 1.31–2.50); consume more alcohol (aOR =1.84, 95% CI: 1.35–2.52), smoke more cigarettes (aOR =2.98, 95% CI: 2.04–4.36); postpone COVID-19 vaccination schedule (aOR =1.82, 95% CI: 1.37–2.41); feel highly stressful (aOR =1.45, 95% CI: 1.18–1.77); and perceive higher likelihood of death from the COVID-19 (aOR =1.80, 95% CI: 1.43–2.26). Conclusions: The presence of NCDs was associated with a higher risk of unhealthy behaviours and poorer mental health outcomes during the COVID-19 pandemic. Further research should evaluate different interventions for improving COVID-19 experiences, behaviours and mental health outcomes among various vulnerable individuals with NCDs.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: